International Society for the Study of Women's Sexual Health

NEWS

Flibanserin recommended for approval by the FDA Advisory Committee Panel

Dear ISSWSH members,
It is with great excitement that I share the announcement that flibanserin, a drug for hypoactive sexual desire disorder (HSDD) developed by Sprout Pharmaceuticals, was recommended for approval by the FDA Advisory Committee Panel on June 4, 2015.

This event opens the door for the first treatment for women suffering from HSDD, but more importantly sends the message that the FDA is now willing to entertain new drug applications from other companies. We are optimistic that this occurrence will instigate more research and eventually other therapeutic options. We also offer deep gratitude to many of our members who played a key role in this decision by voting as members of the FDA Advisory Panel, speaking as presenters on behalf of the sponsor, providing testimony during the Open Public Hearing, and caring for patients who also spoke at the Hearing.  

As a multidisciplinary, scientific organization dedicated to research, clinical practice, and education, we are poised to develop and disseminate clinical practice guidelines regarding screening, diagnosis, and management strategies. Through our robust infrastructure of educational programs, we will ensure appropriate, safe, and selective treatment of HSDD with flibanserin when final approval comes.

Most sincerely,
Sharon J. Parish, MD, IF
ISSWSH President, 2014-2016

Save the Date


ISSWSH Fall Course 2017

  November 2-4, 2017  132 days left
  DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...


ISSWSH Annual Meeting 2018

  February 8-11, 2018  230 days left
  Hilton San Diego on Mission Bay
San Diego, CA, USA

Read more...

Latest Tweets

ISSWSH faculty presented very successful CME symposium on HSDD at IUGA 42nd Annual Meeting in Vancouver, Canada… https://t.co/JqJwCdE9p7 ISSWSH
RT @ISSM_INFO: Sometimes, women experience premature orgasm – climaxing before they wish to. https://t.co/ES4YW59X9H https://t.co/uz4OyWT0… ISSWSH
Many ISSWSH members spent a fruitful day in San Diego filming online e-learning modules. Watch for the finished products this fall! ISSWSH

Contact Details

ISSWSH Executive Office
PO Box 1233
Lakeville, MN 55044
USA

Phone: +1 (952) 683 9025
Fax: +1 (612) 808 0491
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.